Purpose To compare national trends and perinatal outcomes following the use of ejaculated versus surgically acquired sperm among IVF cycles with male factor infertility. Methods This retrospective cohort includes US fertility clinics reporting to the National ART Surveillance System between 2004 and 2015. Fresh, non-donor IVF male factor cycles (n = 369,426 cycles) were included. We report the following outcomes: (1) Trends in surgically acquired and ejaculated sperm. (2) Adjusted risk ratios comparing outcomes for intracytoplasmic sperm injection (ICSI) cycles using surgically acquired (epididymal or testicular) versus ejaculated sperm. (3) Outcomes per noncanceled cycle: biochemical pregnancy, intrauterine pregnancy, and live birth (≥ 20 weeks). (4) Outcomes per pregnancy: miscarriage (< 20 weeks) and singleton pregnancy. (5) Outcomes per singleton pregnancy: normal birthweight (≥ 2500 g) and full-term delivery (≥ 37 weeks). Results Percentage of male factor infertility cycles that used surgically acquired sperm increased over the study period, 9.8 (2004) to 11.6% (2015), p < 0.05. The proportion of cycles using testicular sperm increased significantly over the study period, 4.9 (2004) to 6.5% (2015), p < 0.05. Among fresh, non-donor male factor ART cycles which used ICSI (n = 347,078 cycles), cycle, pregnancy, and perinatal outcomes were statistically significant but clinically similar with confidence intervals approaching one between cycles involving epididymal versus ejaculated sperm and between testicular versus ejaculated sperm. Results were similar among cycles with a sole diagnosis of male factor (no female factors), and for the subset in which the female partner was < 35 years old. Conclusion Among couples undergoing ART for treatment of male factor infertility, pregnancy and perinatal outcomes were similar between cycles utilizing ejaculated sperm or surgically acquired testicular and epididymal sperm.
Introduction
Since the first in vitro fertilization (IVF) baby was born in 1978, assisted reproductive technology (ART) has continued to allow an increasing number of infertile couples to have biologically related children. Because conventional IVF requires motile sperm, men with non-motile or poorly motile sperm following surgical sperm retrieval from the testis or epididymis are not good candidates for conventional IVF. The development of intracytoplasmic sperm injection (ICSI), which allows for the fertilization of an egg with non-motile sperm, broadened the autologous IVF options for men with male factor infertility.
The use of ICSI has increased steadily over the past 25 years [1] . Sperm used for ICSI may be ejaculated or surgically retrieved by epididymal aspiration, testicular biopsy, or testicular extraction with or without microscopic assistance. As men with azoospermia are often faced with a decision regarding whether or not to undergo a surgical sperm retrieval to facilitate IVF with autologous sperm, additional data regarding IVF cycle outcomes using surgically acquired sperm may be helpful in guiding their counseling and decision-making. To our knowledge, only a few single-center studies have been published detailing the outcomes among cycles using surgically acquired sperm [2] [3] [4] [5] [6] , particularly in comparison to those using ejaculated sperm [7, 8] , among men with male factor infertility. Some of these studies specifically investigated outcomes among cycles for which sperm was acquired from either the epididymis [9] [10] [11] [12] or the testes [10, [13] [14] [15] [16] [17] [18] [19] [20] , but were limited by small sample size. Additionally, prior studies using national data focused primarily on IVF cycle outcomes rather than perinatal outcomes [21] .
We used the National ART Surveillance System (NASS) data from 2004 through 2015 to calculate the trends in use of surgically acquired sperm among all IVF cycles carrying a diagnosis of male factor infertility during this time period. We also investigated the association between use of surgically acquired versus ejaculated sperm and cycle and pregnancy outcomes among fresh autologous IVF ICSI cycles including a male factor infertility diagnosis.
Methods
As a result of the Fertility Clinic Success Rate and Certification Act of 1992, over 95% of US ART clinics report all ART cycles to the Centers for Disease Control and Prevention's National ART Surveillance System (NASS) annually, including patient and cycle characteristics, treatment procedures, and cycle outcomes [22] . Using NASS data from 2004 through 2015, we included all fresh, non-donor IVF cycles with a diagnosis of male factor infertility (n = 369,426 cycles). Donor sperm and donor oocyte cycles were excluded. We used the Cochrane Armitage test to assess trends in proportions of surgically acquired sperm use (testicular or epididymal) among all fresh, non-donor cycles with a diagnosis of male factor infertility over the study period.
Among fresh, non-donor IVF cycles with male factor infertility, we compared the distribution of patient and cycle characteristics in each of the sperm acquisition categories, surgically acquired (testicular or epididymal) and ejaculated (standard), using Pearson's chi-square test. Cycles using surgically acquired sperm in which ICSI was not reported (n = 678) were excluded as ICSI is required for fertilization using non-motile testicular sperm resulting in inclusion of 368,499 cycles. Using multivariable log binomial regression to estimate relative risk, among cycles using intracytoplasmic sperm injection (ICSI) (n = 347,078 cycles), we investigated the relationship between use of epididymal or testicular sperm and cycle/pregnancy outcomes including (1) outcomes per transfer: biochemical pregnancy, intrauterine pregnancy, and live birth (≥ 20 weeks), (2) outcomes per pregnancy: miscarriage (< 20 weeks) and singleton pregnancy, and (3) outcomes per singleton pregnancy: normal birth weight (≥ 2500 g) and fullterm delivery (≥ 37 weeks). Cycles were restricted to those involving ICSI to help ensure that the comparison groups were less heterogeneous; the subset of male factor infertility cycles using ejaculated sperm that did not use ICSI may have had very mild male factor infertility and would not be an ideal comparison to cycles in which men required surgical sperm acquisition. Potential confounders associated with both the exposure and the outcome were selected a priori; we adjusted for the following variables: embryo stage, number of embryos transferred, number of supernumerary embryos cryopreserved, and prior history of vasectomy. Subgroup analyses were also performed among ICSI cycles with a diagnosis of male factor infertility only (i.e., no documented female infertility factors) (n = 11,491 cycles) and among cycles with male factor infertility only with a female partner age under 35 years (n = 6721 cycles). These subgroup analyses were performed in an attempt to isolate male factor, by removing female factors and female age from the equation. All analyses were conducted using SAS version 9.4 (SAS Institute Inc.). p values less than 0.05 were considered statistically significant. The Centers for Disease Control and Prevention institutional review board approved this study.
Results
Over the study period, 369,426 IVF fresh non-donor cycles with a diagnosis of male factor infertility were performed in the USA. The number involving surgically acquired sperm (testicular plus epididymal) ranged from 2896 cycles in 2004 to 3152 cycles in 2015, and the proportion of cycles using surgically acquired sperm increased from 9.8% in 2004 to 11.6% in 2015, p < 0.05 (data not shown). The number of cycles involving ejaculated sperm ranged from 26,755 cycles in 2004 to 24,146 cycles in 2015. Among cycles with male factor infertility, 37,925 cycles involved surgically acquired sperm. The proportion of cycles using testicular sperm source increased significantly from 4.9% in 2004 to 6.5% in 2015, and the proportion using epididymal source fluctuated from 4.9% in 2004 to 5.1% in 2015, p < 0.05 (Fig. 1) .
Among the included 368,499 fresh non-donor cycles, the female partners of those using surgically acquired sperm were significantly less likely than those using ejaculated sperm to have an additional infertility diagnosis, or to have had a prior spontaneous abortion (Table 1) . Patterns in female partner age, race/ethnicity, body mass index, number of prior IVF cycles, and number of prior pregnancies were similar between cycles using surgically acquired vs. ejaculated sperm; statistical significance for these comparisons likely reflects the very large sample size. With regard to cycle level characteristics, cycle cancelation was most common among cycles with testicular biopsy-acquired sperm (Table 2) . Female ovarian stimulation regimens, resultant oocyte yield, and incidence of ovarian hyperstimulation were similar among all cycle types; statistical significance for these comparisons was probably due to the very large sample size; with very large sample size, statistical significance is achieved when the absolute difference between groups is small and when clinical significance may not exist (Table 2) . ICSI was used in over 92% of all male factor infertility cycles. ICSI was used more frequently in cycles involving surgically acquired sperm (98.1% in the testicular sperm group, 97.1% in the epididymal sperm group, and 92.5% in the ejaculated sperm group). With respect to number and timing of embryo transfer, two-embryo transfer and embryo transfer at the cleavage stage were most frequent in all groups. Use of assisted hatching was approximately 40% in all groups. Number of supernumerary embryos cryopreserved was highest in the ejaculated group. Among fresh, non-donor ICSI cycles with male factor infertility (n = 347,078 cycles), use of epididymal, as compared to ejaculated, sperm was not associated with a difference in rate of biochemical pregnancy (aRR = 1.02, CI = 0.97-1.08); however, epididymal sperm use was associated with a statistically increased rate of intrauterine pregnancy (aRR = 1.02, CI = 1.01-1.04) and live birth (aRR = 1.03, CI = 1.01-1.05) ( Table 3) . Use of sperm acquired by testicular biopsy, as compared to ejaculated sperm, was not associated with increased rate of biochemical pregnancy (aRR = 0.95, CI = 0.90-1.00) but was associated with increased rates of intrauterine pregnancy (aRR = 1.04, CI = 1.02-1.05) and live birth (aRR = 1.03, CI = 1.02-1.06). The likelihood of miscarriage was not different for epididymal or testicular sperm, as compared to ejaculated sperm (aRR = 0.96, CI = 0.91-1.02 and aRR = 1.00, CI = 0.96-1.06, respectively). The same was true for singleton pregnancy (aRR = 1.00, CI = 0.98-1.02 for epididymal sperm and aRR = 1.00, CI 0.97-1.02 for testicular sperm). Among singleton pregnancies, there was no difference in likelihood of normal birth weight delivery or of fullterm delivery in the surgically acquired sperm groups, as compared to the ejaculated sperm group.
In the subgroup analysis of fresh, non-donor cycles with only a male factor infertility diagnosis (n = 166,171), there were no significant differences between each surgically acquired sperm group and the ejaculated group for any of the investigated outcomes (Table 4 ). In the subgroup analysis of fresh, non-donor cycles with only a male factor diagnosis with a female partner under 35 years of age (n = 6721 cycles), there were no significant differences between each surgically acquired sperm group and the ejaculated sperm group for any of the investigated outcomes (data not shown).
Discussion
The percentage of cycles with a male factor infertility diagnosis that used surgically acquired sperm increased over the study period and was mostly driven by the increase in surgically acquired testicular sperm. Among transfers in fresh, nondonor ICSI cycles with a male factor infertility diagnosis, pregnancy, and perinatal outcomes were clinically similar (confidence intervals included or approached 1) between cycles involving epididymal versus ejaculated sperm and testicular versus ejaculated sperm. Results were similar among cycles with a sole diagnosis of male factor infertility, and for the subset of such cycles in which the female partner was under 35 years old. While prior studies have investigated cycle level outcomes such as fertilization rate, implantation rate, and pregnancy rate for surgically acquired sperm used in IVF cycles [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , this is one of the first studies to use national US ART data to explore perinatal outcomes including miscarriage, term delivery, and normal birth weight delivery. Several prior studies with smaller sample sizes also showed similar neonatal outcomes between infants conceived using either testicular or ejaculated sperm [23] [24] [25] [26] . The clinical similarity in pregnancy and live birth rates per transfer, miscarriage per pregnancy, and favorable perinatal outcomes (term delivery and normal birth weight delivery) between IVF cycles in which sperm was surgically acquired, from the testis or epididymis, versus ejaculated sperm, is reassuring for couples with severe male factor infertility who may be considering the use of surgically acquired sperm. More specifically, this study affirms the findings of a prior national retrospective study using 2004 to 2008 data that compared live birth rates among male factor ICSI cycles, which found no difference in live birth rate per cycle between those with male factor infertility only, compared to those with tubal factor only infertility [21] . Building upon the previously published results, our study uses recent data, specifically investigates sperm acquisition source, and investigates perinatal outcomes in addition to live birth.
The study is strengthened by the inclusion of 97% of ART cycles performed in the USA, its generalizability to other couples undergoing IVF in the USA, the large number of included cycles, and the validation of a select number of clinic responses conducted annually as part of routine data validation procedures in NASS. Additionally, we were able to control for confounders, such a prior vasectomy, that may impact cycle, pregnancy, and perinatal outcomes.
The study is limited by the lack of information regarding more detail of underlying male infertility diagnosis, such as non-obstructive azoospermia, obstructive azoospermia, or another semen parameter abnormality. Future NASS data collection will incorporate some of these additional characteristics, and it is possible that future analyses will demonstrate differences in pregnancy and perinatal outcomes with respect to varying etiology and severity of male factor infertility. This study also does not address surgical technique. Surgical skill and technique vary from one urologist to another; some use microsurgical technique and others do not, which could also influence the choice of sperm acquisition source. Finally, the study is subject to the weaknesses associated with large retrospective database studies such as the inability to randomize Since severity of semen parameter abnormality can affect how sperm are obtained for IVF, men with male infertility can be reassured that IVF cycle and perinatal outcomes are similar between testicular or epididymal and ejaculated sperm. Involvement of a urologist with infertility subspecialty training is a reasonable consideration in men with severely abnormal semen parameters. Future studies that evaluate long-term child outcomes and include more about the male partner's characteristics, the specifics of the surgical technique used for acquisition, and the resultant embryo quality, may inform clinical practice and counseling.
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